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Abstract
The National Reference Centre for Staphylococci and Enterococci in Germany has received
an increasing number of clinical linezolid-resistant E. faecium isolates in recent years. Five
isolates harbored a cfr(B) variant gene locus the product of which is capable of conferring
linezolid resistance. The cfr(B)-like methyltransferase gene was also detected in Clostridium
difficile. Antimicrobial susceptibility was determined for cfr(B)-positive and linezolid-resistant
E. faecium isolates and two isogenic C. difficile strains. All strains were subjected to whole
genome sequencing and analyzed with respect to mutations in the 23S rDNA, rplC, rplD and
rplV genes and integration sites of the cfr(B) variant locus. To evaluate methyltransferase
function, the cfr(B) variant of Enterococcus and Clostridium was expressed in both E. coli
and Enterococcus spp. Ribosomal target site mutations were detected in E. faecium strains
but absent in clostridia. Sequencing revealed 99.9% identity between cfr(B) of Enterococcus
and cfr of Clostridium. The methyltransferase gene is encoded by transposon Tn6218 which
was present in C. difficile Ox3196, truncated in some E. faecium and absent in C. difficile
Ox3206. The latter finding explains the lack of linezolid and chloramphenicol resistance in
C. difficile Ox3206 and demonstrates for the first time a direct correlation of elevated linezo-
lid MICs in C. difficile upon cfr acquisition. Tn6218 insertion sites revealed novel target loci
for integration, both within the bacterial chromosome and as an integral part of plasmids.
Importantly, the very first plasmid-association of a cfr(B) variant was observed. Although we
failed to measure cfr(B)-mediated resistance in transformed laboratory strains the occur-
rence of the multidrug resistance gene cfr on putatively highly mobile and/or extrachromo-
somal DNA in clinical isolates is worrisome with respect to dissemination of antibiotic
resistances.
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Introduction
The oxazolidinone linezolid represents an antibiotic of last resort used to treat severe infec-
tions that are caused by multidrug-resistant Gram-positive bacteria such as methicillin-resis-
tant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus spp. (VRE).
According to a recent Threats Report from the Centre for Disease Control and Prevention,
MRSA and VRE are listed under serious threats which require public health monitoring
(http://www.cdc.gov/drugresistance/threat-report-2013/). Considered as an important noso-
comial pathogen VRE can cause life-threatening diseases including septicemia, endocarditis
or urinary tract infections. After the approval of linezolid in 2000, emergence of resistant
strains upon linezolid therapy has been reported for both VRE and vancomycin-susceptible
enterococci (VSE) [1, 2]. Although linezolid-resistant enterococci (LRE) are generally
detected at low prevalence in Europe, the National Reference Centre (NRC) for Staphylo-
cocci and Enterococci at the Robert Koch Institute recognized an increasing number of LRE
in German hospitals [3].
Linezolid targets the ribosomal machinery by inhibiting formation of the translation ini-
tiation complex, hence protein synthesis [4]. In addition to mechanisms such as mutations
in the 23S rDNA or ribosomal protein genes rplC, rplD and rplV, resistance to linezolid is
mediated by acquisition of the cfr RNA methyltransferase [5–8]. However, cfr not only con-
fers insusceptibility to oxazolidinones, but also to a broad range of antibiotics collectively
known as PhLOPSA (Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins and Strepto-
gramin A) [5].
Unlike staphylococci, where a combination of site-specific mutations within the rDNA
and/or ribosomal proteins and the expression of cfr are jointly responsible for the development
of a resistance phenotype [9, 10], reports concerning cfr-mediated resistance in enterococci
remain scarce. Up to now, the majority of studies described the accumulation of mutations
affecting the ribosomal machinery [2, 11, 12]. Although the presence and expression of cfr in
enterococci has been reported previously, the impact of conferring resistance to enterococci
isolates is still under debate [13–17]. It must be noted that two isoforms of the cfr gene exist in
enterococci, one of which is highly similar to cfr from staphylococci and the other one being
almost identical to a cfr-like gene from Clostridium difficile [14, 16, 18]. The latter is now
termed cfr(B) and located on the composite transposon Tn6218 [16]. Adding to the complexity
of linezolid resistance, enterococci from China and Italy were shown to carry optrA, a gene
encoding an ABC-transporter capable of mediating oxazolidinone and phenicol insusceptibil-
ity [17, 19, 20].
It has been reported that C. difficile isolates with elevated MICs harbor cfr [21]; however, it
has been shown just recently that episomal expression of the very same gene confers the
PhLOPSA phenotype in E. coli [22]. Nevertheless, until today it remains to be determined
whether cfr as a sole mechanism is able to mediate PhLOPSA phenotypic resistances in wild-
type Clostridium.
In the present study, we analyzed the first clinical cfr(B)- positive E. faecium isolates from
German hospital patients. The methyltransferase gene was shown to be a close homolog of cfr
(B) from American E. faecium isolates and from C. difficile. As part of a full length or truncated
version of transposon Tn6218 the cfr(B) variant described herein showed novel sites for inte-
gration and, most importantly, plasmid-association. Expression of this cfr(B) variant from
enterococci and of C. difficile failed to recover the PhLOPSA phenotype in E. coli and Entero-
coccus spp. However, analysis of a closely related strain set of C. difficile clinical isolates demon-
strates for the first time that the Cfr-like methyltransferase is able to mediate oxazolidinone
and phenicol resistance in the important gut commensal and nosocomial pathogen.
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Materials and Methods
Strains used in this study
Five E. faecium strains isolated from German hospital patients and exhibiting linezolid resis-
tance (Table 1) were tested positive for cfr by PCR as described previously [3, 23]. Two closely
related C. difficile strains were isolated in Oxford, United Kingdom in 2012 and are part of a
small cluster of geographically and temporally linked cases (Kate Dingle, personal communica-
tion); however, Ox3206 lacks the mobile element cfr-Tn6218 which is present in Ox3196
(HG002389) [24].
Antimicrobial susceptibility testing
The antimicrobial susceptibility of Enterococcus spp. isolates was determined by broth micro-
dilution (determination of minimal inhibitory concentrations, MICs) according to EUCAST
and applying EUCAST MIC breakpoints for interpretation of the results (www.eucast.org);
Etest1 linezolid (LZD) (bioMérieux, Nürtingen, Germany) was used to confirm results. In
addition, transformants of E. coli Top10, E. faecium 64/3 and E. faecalis JH2-2 were analysed
for susceptibility to LZD, chloramphenicol (CMP) and florfenicol (FFC). Please note that
according to the latest version of CLSI document VET01-A4 no clinical breakpoints are pro-
vided for FFC. In case of C. difficile Etest1 for LZD and CMP were used to determine the MIC
under anaerobic conditions. Please note that there are no MIC clinical breakpoints available
for C. difficile.
DNA extraction
Enterococcus strains were grown overnight in BHI broth at 37˚C. C. difficile were routinely
grown at 37˚C on Brucella agar supplemented with 5% blood, 1 mg/L vitamin K and 5 mg/L
hemin. Air-sealed containers were adjusted to anaerobic conditions using AnaeroGen™ sachets
(Thermo Fisher Scientific, Germany). DNA was extracted from cell material obtained from
agar plates (Clostridium) or from overnight cultures (Enterococcus) using the DNeasy blood
and tissue kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
Molecular characterization of linezolid resistance and whole genome
sequencing
The ratio of 23S rDNA wildtype and mutated alleles was determined as published previously
[25]. In brief, amplified PCR products were digested with NheI which discriminates between
wildtype and mutated alleles (position G2576T) and fragments were separated thereafter on
a microfluidic chip using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA). Densitometric analysis allows a qualitative assessment of wildtype and mutated alleles
as well as quantification of both allele types per isolate. To analyse possible linezolid resis-
tance-mediating mutations rplC, rplD, rplV were examined from whole genome sequence
data. To this end, 1 ng of extracted DNA was subjected to library preparation using the Nex-
tera XT Library Prep Kit according to the manufacturers’ instructions (Illumina). Whole
genome sequencing (WGS) was performed on a MiSeq benchtop instrument in paired-end
with a maximum of 300 bp read length (MiSeq Reagent Kit v3, 600 cycles, Illumina). For
enterococci, obtained sequences were compared to genomic data from E. faecium DO/TX16
(NC_017960), whereas C. difficile R20291 (FN545816) served as a reference for strains
Ox3196 and Ox3206.
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Whole genome comparison of C. difficile strains
Genomic reads from C. difficile Ox3196 and Ox3206 were obtained by next generation
sequencing (see above) and assembled de novo using the open access assembly pipeline
a5-miseq [26]. Subsequently, obtained contigs were concatenated and annotated by RAST
[27]. Comparison of whole genome content was carried out using the BLAST Ring Image Gen-
erator (BRIG) program [28]. Determination of loci which were absent in C. difficile Ox3206
was performed by mapping of reads to the concatenated and annotated sequence from C. diffi-
cile Ox3196 using the Geneious software (version 9.1.3).
Phylogenetic analysis of cfr(B)-positive E. faecium
To determine the phylogeny of the 5 cfr(B)-positive E. faecium, Single Nucleotide Polymor-
phisms (SNPs) were identified by using a pipeline based on BWA v0.7.12-r1039 [BWA-SW;
[29]] for mapping to reference strain E. faecium 64/3 (CP012522) and VarScan v2.3 [30] for
variant calling. SNPs located within a 300 bp distance, or less, from each other were excluded
as they might represent variants introduced by recent recombination events. A maximum like-
lihood tree was inferred from a total of 874 SNP positions by utilizing the PhyML algorithm of
the seaview program and 1000 iterations for branch validation.
Determination of Tn6218-cfr(B) insertion sites in E. faecium
To differentiate between plasmid and chromosomal insertion of Tn6218 in E. faecium isolates,
bacterial genomic DNA was treated with S1 nuclease in order to linearize plasmids which were
separated thereafter by PFGE prior to Southern hybridization using a digoxigenin-labelled cfr-
specific probe (Roche Biochemicals, Mannheim, Germany) [31]. The cfr-specific probe was
generated using primers as published previously [23] and E. faecium UW10882 whole genomic
DNA as a template.
For further analyses, de novo assembly of reads from Illumina WGS was carried out as
described above. In order to determine conserved blocks between isolates, obtained cfr(B) vari-
ant-containing contigs were aligned thereafter using the Geneious software. For elucidation of
putative Tn6218 insertion sites, transposon flanking regions were extracted and BLASTn
search was performed. Insertion sites were verified by PCR using oligonucleotides as stated in
S1 Table in a PCR reaction with 12.5 μl of 2 x DreamTaq Green PCR Mastermix (Thermo
Fisher Scientific, Germany), 0.1 μM of each primer and 0.5 μl of isolated DNA in a total reac-
tion volume of 25 μl. Thermocycler conditions were set to 2 min at 94˚C for initial denatur-
ation followed by 30 cycles of 30 sec at 94˚C, 30 sec at 55˚C (S1 Table) and 1–2 min at 72˚C. A
final extension was carried out at 72˚C for 4 min.
Cloning of cfr(B) variants-expressing plasmids
The cfr(B) variant gene from E. faecium UW10882 and C. difficile Ox3196 was amplified by
PCR using Phusion polymerase (Thermo Fisher Scientific, Germany), oligonucleotides
cfr_us_BamHI_fw and cfr_ds_SalI_rv3 (S1 Table) and a protocol as follows: 98˚C for 30 sec
for initial denaturation, 30 cycles of 10 sec at 98˚C, 30 sec at 54˚C-64.5˚C and 60 sec at 72˚C,
and a final extension for 5 min at 72˚C. The primers were designed to bind 220 bp upstream of
the start of protein translation and terminate 127 bp downstream of the stop codon. PCR
products were digested using BamHI and SalI and ligated to appropriately cut vector pEF-25
before transformation of chemically competent E. coli Top10. Positive transformants were
selected on LB agar plates containing 50 mg/L spectinomycin (SPC) and inserts were verified
by Sanger sequencing. Designated plasmids pWJB001 (pEF-25 + cfr(B) variantEnterococcus) and
cfr(B) Variant from Enterococcus faecium
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pWJB002 (pEF-25 + cfrClostridium) were used to electroporate laboratory strains E. faecium 64/3
and E. faecalis JH2-2 and transformants were selected on BHI agar supplemented with 200
mg/L SPC [adapted from [32]].
Expression analyses of the cfr(B) variants in Enterococcus spp.
Two independent transformants of E. faecium 64/3 (pWJB001 or pWJB002) and E. faecalis
JH2-2 (pWJB001 or pWJB002) were analyzed with respect to antibiotic insusceptibility. Gene
expression of the cfr(B) variant targets was evaluated by total RNA extraction and reverse tran-
scription as described elsewhere [33]. Quantification of cDNA was carried out using the
DyNAmo ColorFlash SYBR Green qPCR kit (Thermo Fisher Scientific, Germany) in a CFX96
qPCR instrument (Bio-Rad, Germany). Primers cfr_UW10882_qPCR_fw and
cfr_UW10882_qPCR_rv (S1 Table) were used at a final concentration of 0.1 μM in a 20 μl
reaction containing 5 μl of 1:10 diluted cDNA for target amplification or 5 μl 1:1000 diluted
cDNA for amplifying the 16S reference gene [33]. Thermocycler conditions were set to: 2 min
at 95˚C, 45 cycles of 10 sec at 95˚C and 30 sec at 60˚C and a melting curve was determined in
the range from 60–98˚C.
Filter-mating experiments
Transfer capabilities of transposon Tn6218 was determined by filter-mating experiments using
E. faecium 64/3, E. faecalis OG1RF or E. faecalis JH2-2RF as recipient strains and as published
previously [34]. The following isolates were used as donors: E. faecium strains UW10882,
UW11590, UW11733, UW11858, UW12727 and C. difficile Ox3196. The bacterial mixture was
placed on a nitrocellulose filter on BHI agar plates and in case of Clostridium under anaerobic
conditions to allow overnight transfer of cfr between the two species. Putative transconjugants
of filter-mating experiments were then selected on BHI agar plates containing i) 10 mg/L FFC,
30 mg/L rifampicin (RIF) and 20 mg/L fusidic acid (FUS); ii) 5 mg/L CMP, 30 mg/L RIF and
20 mg/L FUS or iii) plates containing 30 mg/L RIF and 20 mg/L FUS only. Further, putative
transconjugants were screened for acquisition of cfr by PCR.
Nucleotide accession numbers
Raw reads are available from the SRA under accession number SRP078305.
Results
Description of bacterial isolates
Five clinical LRE isolates, collected between 2013 and 2015 from German hospital patients,
were tested positive in cfr-specific PCR screening experiments [3]. The strains exhibited a mul-
tidrug-resistant phenotype with varying levels of MICs to linezolid ranging from 6 mg/L to 48
mg/L (Table 1). Three isolates (UW10882, UW11590, UW12712) were of sequence type (ST)
117, but originated from two distinct geographical regions (Table 1). Further, 4/5 strains were
positive for either vanA or vanB whereas UW10882 did not harbor a glycopeptide resistance
gene (Table 1). Investigation of the cfr locus (outlined below) revealed a highly similar genomic
structure to a cfr gene located on transposon Tn6218 from C. difficile. Thus, we further ana-
lyzed the cfr-positive isolate C. difficile Ox3196 (ST37) (HG002389) and compared it to C. diffi-
cile Ox3206 (ST37) a close but cfr-negative relative of Ox3196. Phenotypic characterization
revealed an 8-fold difference in linezolid MIC between the cfr-positive and the cfr-negative C.
difficile isolate (Table 1). Clostridia were also analyzed for resistance to chloramphenicol,
thereby showing MICs of 24 mg/L for Ox3196 compared to 2 mg/L for Ox3206, respectively.
cfr(B) Variant from Enterococcus faecium
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Analyses of linezolid resistance-associated DNA mutations and of the cfr
(B) variant methyltransferase gene
Genotypic characteristics likely associated with linezolid resistance were determined for each
of the five Enterococcus and the two Clostridium isolates. First, mutations in the 23S rDNA
were analyzed by NheI restriction. Different ratios of wildtype to mutated alleles were found
for E. faecium UW10882 and UW12712 (Table 1). No respective mutation of the 23S rDNA
alleles was detected in C. difficile or the remaining E. faecium. Second, WGS was carried out to
extract genomic information regarding mutations in loci encoding for ribosomal target pro-
teins. This yielded two mutations within rplD (L4) for E. faecium UW11590 and UW11858
(Table 1). A triplet nucleotide insertion (211GGT213) and thus addition of amino acid glycine
at the respective position was detected in both cases. Interestingly, Enterococcus isolates har-
boring 23S rDNA mutations showed no additional alterations in genes encoding for the three
ribosomal proteins investigated (Table 1). In case of C. difficile no differences were detected
between the two isolates. However, synonymous mutations in rplC were found when com-
pared to the reference genome C. difficile R20291 (not shown). Moreover, the entire set of
WGS derived reads was mapped to the recently identified oxzolidinone and phenicol resis-
tance gene optrA [19]; however, none of the strains carried optrA (Table 1). In general, no
apparent correlation was observed between the occurrence of certain nucleotide mutations
and the level of linezolid resistance.
The cfr genes from the investigated E. faecium and C. difficile isolates were extracted from
WGS data and the predicted protein sequences were aligned thereafter to previously pub-
lished Cfr from enterococci and staphylococci [16, 35]. Notably, Cfr from E. faecium
UW12712 showed 99.7% identity to the recently identified Cfr(B) from E. faecium of human
origin [16], hence differing in a single amino acid at position 314 (K314E) only. Cfr of the
remaining Enterococcus exhibited 99.4% identity to Cfr(B) due to an additional mutation at
position 247 which results in an arginine by lysine substitution (R247K). On the basis of
homology, Cfr(B)-like sequences of the five E. faecium isolates were consequently termed Cfr
(B) variants.
The Cfr(B) variants were 100% identical between E. faecium UW10882, UW11590 and
UW11733. Except for Cfr(B) from E. faecium UW12712, Cfr(B) variants from the clinical E.
faecium isolates showed 99.7% identity to Cfr from C. difficile with a single isoleucine to valine
(I294V) substitution. Likewise, E. faecium UW12712 displayed this very same mutation, but
additionally carried the already mentioned lysine by arginine substitution at position 247
(K247R) compared to Cfr from C. difficile. Similar to Cfr(B), Cfr(B) variants of the here
described E. faecium strains were remarkably different to Cfr from staphylococci (74.1% for E.
faecium UW12712 and 78% for the other four E. faecium isolates).
Cfr-dependent linezolid resistance in C. difficile
NheI restriction analysis and WGS comparisons of C. difficile Ox3196 (cfr-Tn6218-positive)
and C. difficile Ox3206 (cfr-Tn6218-negative) revealed no difference in linezolid-associated
genomic mutations (Table 1). It has recently been shown that ectopic expression of cfr from C.
difficile in E. coli confers resistance to the recipient bacteria [22]; however, cfr-dependent insus-
ceptibility to linezolid in C. difficile is still under debate [21, 22]. In order to verify cfr-mediated
linezolid and chloramphenicol resistance in C. difficile (see above) and to exclude the lack of
genomic content other than Tn6218 in strain Ox3206 as the source for reduced susceptibility
(Table 1) whole genome comparison of both isolates was carried out utilizing the BLAST Ring
Image Generator (BRIG) program. As illustrated in Fig 1 only Tn6218 and two Tn916-like ele-
ments were absent in C. difficile Ox3206 (Fig 1).
cfr(B) Variant from Enterococcus faecium
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Subsequent RAST annotation and detailed examination of the genomic regions encoded by
the two Tn916-like elements produced open reading frames for a Tn916 transcriptional regula-
tor, a putative transposon integrase (only one Tn916-like element), multiple hypothetical pro-
tein and two dihydrofolate reductase genes (one Tn916-like element only) (not shown). Thus,
it is feasible to attribute elevated linezolid MICs of C. difficile Ox3196 to the presence of the cfr-
containing transposon Tn6218.
Determination of the genetic environment of the cfr(B) variant gene locus
of clinical E. faecium isolates
It has been reported that cfr from C. difficile and cfr(B) from E. faecium are encoded by trans-
poson Tn6218 and Tn6218-like elements, respectively [16, 24]. In order to disclose the genetic
environment of the cfr(B) variants from the German clinical E. faecium isolates, next genera-
tion sequencing was carried out and cfr(B)-containing contigs were examined after de novo
assembly in a way that Tn6218-like structures were extracted and compared to Tn6218 from
C. difficile (HG002389) and to cfr(B) and adjacent regions from E. faecium (KR10408) (Fig 2).
E. faecium UW10882, UW11590 and UW11733 harbor a Tn6218-like element highly simi-
lar to Tn6218 from C. difficile (HG002389) (Fig 2). Nucleotide alignment revealed an identical
and conserved block between the four strains of 6,900 bp and spanning the methyltransferase
locus. However, ORFs located upstream of the cfr(B) variant and encoding an integrase, exci-
sionase and putative topoisomerase were less than 97% conserved between Enterococcus and
Clostridium (not shown). Interestingly, E. faecium UW11590 and UW11733 displayed an iden-
tical stretch of 9,733 bp including the integrase locus that differed when compared to
UW10882 (schematic representation in Fig 3). In contrast, examination of regions adjacent to
the cfr(B) variant of E. faecium UW11858 and UW12712 indicated that those strains only har-
bor a truncated version of Tn6218 (Fig 2). The cfr(B) variant locus of E. faecium UW11858
Fig 1. Whole genome comparison of C. difficile Ox3196 and Ox3206. BRIG alignment of the
concatenated genomic contigs obtained by WGS revealed two regions which are absent in C. difficile Ox3206
and harbor Tn916-like related genes. Likewise, the entire transposon Tn6218 (red), containing the cfr
resistance locus, is present in C. difficile Ox3196 only.
doi:10.1371/journal.pone.0167042.g001
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displayed a conserved region of 4,330 bp when compared to Tn6218 from C. difficile and
UW12712 exhibited even less identity to the respective mobile element (in total 1,788 bp; Fig
2). It is worth noting that the genetic environment of cfr(B) variants of E. faecium isolates
described in this study was strikingly different to the cfr(B) locus of the American E. faecium
isolate 448-18961R (KR610408) (Fig 2).
Phylogenetic relationship of German cfr(B)-positive E. faecium isolates
Strain characteristics with respect to sequence type, phenotypic profile, genotype of the vanco-
mycin resistance locus and region of isolation suggests a possible link between isolates
UW11590 and UW12712 (Table 1), although the latter only carries a truncated version of the
Tn6218-like element (Fig 2). Hence, mapping of sequencing reads to reference E. faecium 64/3
was performed to infer the genetic relationship of the five E. faecium strains. As a result, 874
SNPs served as the basis for Maximum Likelihood analysis by the PhyML algorithm. All the
isolates were only distantly related to each other (Fig 3).
Further, a distance matrix extracted from Neighbor-Joining analyses in Geneious demon-
strated that E. faecium UW11590 and UW12712 were separated by 56 SNPs, thus excluding an
immediate close relatedness. In summary, WGS analyses and epidemiological and genotypic
data of the strains as well as their resistance profiles (Table 1) did not indicate a direct interre-
lationship or clonal spread of cfr(B)-positive E. faecium in Germany.
Elucidation of Tn6218-like insertion sites
Tn6218 of C. difficile was reported to be integrated into the bacterial chromosome. Hence,
Southern hybridization experiments of whole plasmid content after S1-nuclease treatment and
PFGE and by using a cfr-specific probe was performed for the cfr(B) variant-expressing E. fae-
cium isolates. As depicted in Fig 4, plasmid-association is suggested for E. faecium UW10882
and UW12712 with an estimated plasmid size of approximately 200 kb and 300 kb, respectively
(Fig 4A and 4B).
Fig 2. Schematic representation of Tn6218 in clinical E. faecium isolates. Different variants of Tn6218-like elements were detected in the five
German cfr(B)-positive E. faecium clinical isolates (UW numbering). UW12712 exhibits a truncated element encoding solely for the cfr(B) variant and a
hypothetical protein of the original composite transposon Tn6218 of C. difficile (HG002389). E. faecium UW10882, UW11590 and UW11733 all harbor
highly similar or even complete identical (UW11590 and UW11733) Tn6218-like structures and gene contents. A comparison of Tn6218 of the clinical
isolates and of C. difficile Ox3196 to the mobile element of the American E. faecium isolate 448-18961R (KR610408) revealed an almost entirely
different gene composition. Numbers represent the length of the published sequence or obtained contig, respectively. Abbreviations: int, integrase; xis,
excisionase; rep, putative topoisomerase; HTH Xre, putative transcriptional regulator; i, integrase core domain fragment; h and hypo, hypothetical
protein; sigma 70, sigma 70 region 4; H, HTH motif coding sequence (CDS); C, CD31680 CDS; r, regulatory protein.
doi:10.1371/journal.pone.0167042.g002
cfr(B) Variant from Enterococcus faecium
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It is worth mentioning that hybridization experiments of phenol/chloroform extracted
whole plasmid content verified results obtained by S1-PFGE (not shown). For detailed disclo-
sure of insertion sites, sequences of regions adjacent to the mobile element were extracted
from cfr(B)-carrying contigs and BLASTn search was performed to reveal respective target
genes or intergenic regions. Table 2 summarizes putative insertion sites which were verified by
PCR as indicated.
However, insertion sites were questionable in some cases, as for instance in silico analysis of
up- and downstream sequences of E. faecium UW10882 Tn6218 yielded two different target
regions which, according to reference plasmid pDO3 from E. faecium DO/TX16 (CP003586),
are located>95 kbp apart from each other. Nevertheless, both loci showed positive PCR results
Fig 3. Maximum likelihood analysis of German cfr(B)-positive E. faecium. hylogenetic analysis inferred from mapping of whole genome
sequencing reads to reference genome E. faecium 64/3 (CP012522) did not indicate a close relationship between the German E. faecium isolates. For
comparative reasons, the length of the putative transposon Tn6218 sequence is indicated by boxes. Strain characteristics such as year and federal
state of isolation as well as sequence types are listed. Abbreviations: NRW, North Rhine-Westphalia; SA, Saxony-Anhalt; BW, Baden-Wuerttemberg;
SLV, single locus variant.
doi:10.1371/journal.pone.0167042.g003
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by amplifying Tn6218 and adjacent sequences from E. faecium UW10882 and S1-PFGE results
are in support of plasmid localization (Table 2, Fig 4).
Also, we failed to reveal the integration site of the truncated version of Tn6218 (Fig 2) from
E. faecium UW11858 (Table 2). Adjacent regions yielded no hits with BLASTn or showed simi-
larity to conjugational genes from C. perfringens pJIR4150 plasmid sequences or, to a lesser
extent of identity (78% - 83%), to hypothetical proteins of Tn5386 from E. faecium D344R (not
shown). This suggests an environment linked to mobile genetic elements of various origins. It
remains elusive whether the ancestor of UW11858, eventually having received the cfr(B) vari-
ant, already harbored a Tn5386-like element or related MGEs.
Adding to the complexity, target sites for cfr(B)-Tn6218 insertion in E. faecium UW12712
remain speculative as BLASTn of the entire 38,570 bp cfr-contig revealed homologous regions
which could either be allocated to transposon and genomic content or plasmid sequences (not
shown). For instance, about half of the contig showed 93% identity to parts of a conjugation
module and transposase sequences of C. perfringens plasmid pJIR4150; however, reconstruc-
tion of a putative novel plasmid was not achieved which is most likely due to the size and
highly plastic nature of enterococcal extrachromosomal DNA. Nevertheless, plasmid-associa-
tion as proposed in silico is in accordance with results obtained by Southern hybridization
which demonstrated plasmid integration of the cfr(B) variant locus for UW12712 (Fig 4).
Integrity of the contig was verified by PCR bridging the truncated Tn6218-like fragment and
flanking regions (Table 2).
Fig 4. Determination of plasmid content and localization of the cfr(B) variant in the five E. faecium
isolates. (A) Separation of whole and linearized plasmid content by S1-PFGE. (B) Hybridization using a cfr-
specific probe was carried out after transfer of plasmids to a nitrocellulose membrane. The asterisks indicate a
cfr-positive signal (in B) and the corresponding plasmid (in A). S. aureus 8325was used as a reference strain
for estimation of plasmid sizes.
doi:10.1371/journal.pone.0167042.g004
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In summary, Tn6218-like elements showed novel sites of integration in German E. faecium
clinical isolates.
Transformation of cfr-carrying plasmids into E. faecium and E. faecalis
laboratory strains and determination of a cfr(B) variant-mediated
resistance phenotype
In order to exclude that mutations in linezolid resistance-associated genes (see above) are the
sole source for linezolid insusceptibility in cfr(B)-positive E. faecium isolates, the cfr(B) variant
gene locus of both E. faecium UW10882 and of C. difficile Ox3196 was cloned and expressed in
E. faecium 64/3 and E. faecalis JH2-2, respectively. Acquisition of the cfr(B) variant was verified
by colony PCR (not shown) and cfr-mediated resistance to various antibiotics was determined
by broth microdilution (S2 Table). However, introduction of the cfr(B)variant-containing vec-
tors did not confer resistance to the transformants or elicited elevated MICs to the antibiotics
tested (S2 Table). Quantitative PCR was carried out from reverse transcribed RNA to exclude
insufficient transcription as causative for the lack of a resistance phenotype. Thereby, cfr(B)
variant transcripts were detected at high levels in all strains analyzed (not shown).
Conjugational transfer of E. faecium and C. difficile Tn6218
Whole genome sequencing revealed the presence of putatively intact Tn6218 and Tn6218-like
structures in C. difficile Ox3196 and E. faecium UW10882, UW11590 and UW11733, respec-
tively (Fig 2). Also and according to results from Southern hybridization utilizing a cfr-specific
probe, E. faecium UW10882 and UW12712 seem to carry the cfr(B) variant on a plasmid (Fig
4). In order to examine transfer capabilities and thus spread of the resistance cassette, filter-
mating experiments were carried out using E. faecium 64/3 and E. faecalis OG1RF or JH2-2RF
as susceptible recipient strains. Conjugation between C. difficile and enterococci was
Table 2. Insertion sites of the Tn6218-like element in clinical E. faecium isolates.





























UW11733 25,565 bp within EFAU085_RS09245 chromosome
(NC_021994)
yes chromosome
UW11858 42,559 bp within Tn5386-like element chromosome
(NC_021994)
n.a. chromosome




us, upstream; ds, downstream;
↨, insertion site of Tn6218;
n.a., not applicable
doi:10.1371/journal.pone.0167042.t002
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investigated under anaerobic conditions. The antibiotics chloramphenicol or florfenicol were
used as selective markers; however, putative transconjugants were also examined from non-
selective plates in case transfer and expression of the cfr(B) variant fails to mediate a resistance
phenotype as seen in previous experiments (see above). Unfortunately, screening of putative
transconjugants by cfr-specific PCR yielded no positive candidates after repeated filter-mating
experiments and multiple conditions tested.
Discussion
Determination of resistance development to antibiotics of last resort, such as resistance to the
oxazolidinone linezolid, is of global importance with respect to remaining treatment options
for severe infections caused by multidrug-resistant bacteria. As for VRE, linezolid therapy rep-
resents a valuable alternative since the general prevalence of LRE has remained constant 1%
for the last few years (http://www.ars.rki.de) [36]. We herein describe the detailed investigation
of the first cfr(B) variant-containing E. faecium strains isolated from German hospital patients
[3]. Cfr and recently cfr(B) have already been shown to be distributed across various bacterial
species [16, 22, 37] and outbreaks involving cfr-encoding Gram-positive bacteria haven been
reported [38]. However, the impact of cfr on linezolid insusceptibility in E. faecium is still ques-
tionable, as resistance development is based on multiple mechanisms including mutations
affecting the ribosomal machinery [8]. In accordance, detailed molecular investigation of
strains from the present study showed the combination of DNA mutations and presence of a
cfr(B) variant, with isolate UW11733 being the sole exception. No correlation of an increase in
linezolid MIC with respect to acquisition of multiple resistance mechanism could be detected.
This aspect makes it difficult to attribute linezolid resistance to the presence of the cfr(B) vari-
ant in the E. faecium clinical isolates, not least because it has been reported that existence and
expression of cfr in E. faecalis does not necessarily mediate a resistance phenotype [15]. In con-
cordance with the data from Liu et al., we performed heterologous expression of the cfr(B) var-
iant in E. coli and laboratory strains of E. faecium and E. faecalis, but also failed to observe
resistance development in the respective transformants. It must be noted that the cfr gene
from E. faecalis and the cfr(B) variant from German E. faecium strains are markedly different.
Nonetheless, recent examinations of cfr(B) from E. faecium and of cfr from C. difficile clearly
demonstrated that expression in either S. aureus or E. coli confers a similar resistance pheno-
type [16, 22]. Hansen and Vester [22] performed a codon optimization in order to express and
analyze the cfr gene in E. coli, which might explain the lack of resistance of our E. coli transfor-
mants harboring cfr from C. difficile (not shown). However, this does not explain the missing
phenotype when expressing the cfr(B) variant of E. faecium and of C. difficile Ox3196 in labora-
tory strains of E. faecium and E. faecalis. Interestingly, Deshpande and coworkers reported
about isolate E. faecium 18961 which, although carrying cfr(B), failed to develop the full
PhLOPSA phenotype. As for instance, strain 18961 showed only low MIC levels for clindamy-
cin [16]. Likewise, the German isolates UW11733 and UW11858 do not exhibit the entire
PhLOPSA resistance pattern and displayed MIC values for clindamycin below the detection
limit of 0.5 mg/L (not shown). Hence, it remains to be determined whether Cfr(B) methyl-
transferases and variants thereof are causative for resistance development to five classes of anti-
biotics in enterococci. Nonetheless, the cfr(B) variant of UW11733 is highly likely to impact
linezolid insusceptibility (MIC 8 mg/L), as the strain does not carry any additional chromo-
somal mutation nor does it harbor the recently identified oxazolidinone and phenicol resis-
tance gene optrA (Table 2) [17, 19].
As mentioned above, Hansen and Vester confirmed that cfr from C. difficile is able to confer
resistance to E. coli transformants [22]; however, they did not pursue to examine cfr-mediated
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resistance in the parental Clostridium. Also, a previous study could not clearly link the pres-
ence of cfr to elevated levels of linezolid MICs in C. difficile [21]. By analyzing a closely related
set of C. difficile isolates differing only in the presence or absence of cfr- encoding Tn6218 we
demonstrated for the first time that upon acquisition of the transposon C. difficile exhibits ele-
vated MICs to linezolid (Table 1) and chloramphenicol (see above). Importantly, linezolid is
not prescribed for the treatment of C. difficile infections. Nevertheless, clostridia are part of the
human gut microbiota which represents a reservoir for active and mobile resistance determi-
nants [39]. Moreover, C. difficile are known to harbor various conjugative and non-conjugative
transposable elements, some of which encode for chloramphenicol or tetracycline resistance
determinants [40]. Hence, antimicrobial selective pressure imposes a risk to clinical settings
and raised the question whether linezolid resistance encoded by the putatively mobile genetic
element (MGE) Tn6218 is transferable between gut commensal organisms. Successful transfer
of MGEs other than Tn6218 has frequently been demonstrated to occur between C. difficile
and Enterococcus spp. [41–43]. Three of the five E. faecium strains analyzed in this study har-
bor a Tn6218-like transposon highly similar to the one from C. difficile and thus could poten-
tially disseminate the resistance to receptive bacteria. Also, isolates UW10882 and UW12712
carry the cfr(B) variant on plasmids (Fig 4) which were reported to easily facilitate transfer of
linezolid resistance [18, 44, 45]. Also, plasmid-encoded cfr was shown to transfer frequently
between enterococci or staphylococci [15, 18, 37, 45] and in some cases even within bacterial
phyla [35]. A series of filter-mating experiments using all five clinical cfr(B)-positive E. faecium
isolates and C. difficile Ox3196 as donors were conducted but failed to transfer the resistance
to laboratory strains of E. faecium or E. faecalis, respectively. The most obvious explanation is
represented by the inability of the cfr(B) variant to confer elevated MICs to florfenicol (see
above) which was used as a selective marker in filter-mating experiments. Further, Tn6218
belongs to the family of non-conjugative transposons and thus lacks a functional conjugation
machinery. Mobilization of MGEs, though possible [46], would require specific host determi-
nants which might be absent in our donor strains tested In accordance, some studies also
report about ineffective transfer from Enterococcus spp. to staphylococci or vice versa [18, 47].
Thus, the questions of whether or not the cfr(B) variant could to be disseminated amongst
enterococci by conjugation requires further investigation.
In general, cfr is an integral part of multiple MGEs incorporated into plasmids or the
chromosomal backbone [37]. The various Tn6218-like elements of the German E. faecium
strains revealed target sites for transposon integration which were entirely different to the
ones reported for cfr and cfr(B) from enterococci so far [16, 37]. Phylogenetic investigations
did not indicate clonal relatedness of the five E. faecium isolates and thus suggest an inde-
pendent acquisition of the Tn6218-like and cfr(B) variant-containing element. In addition,
chromosomal rearrangements preceding or following the uptake of the resistance determi-
nant are highly likely for isolate UW10882, as cfr-flanking regions yielded two different
insertion sites which, according to reference pDO3, would be located far apart from each
other. Last but not least, the two truncated variants of the Tn6218-like element investigated
herein document the modular structure of such elements [24] and add to the pool of newly
composed cfr-containing MGEs.
In conclusion, we could demonstrate for the first time that cfr is able to mediate linezolid
resistance in a clinical C. difficile isolate. Most importantly, this is the first report of cfr(B) in
German E. faecium strains and the first mentioning of plasmid-localization of a cfr(B) variant
in enterococci of clinical origin. As a consequence, surveillance of cfr-positive strains and
detailed investigation of the genetic requirements for resistance acquisition and expression is
essential to prevent emergence and spread of untreatable multidrug-resistant pathogens.
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